Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...

The PCMPA has slammed Moderna over an unapproved WhatsApp message that offered children 1,500 pounds sterling ($2,000) to ...

GSK's decision not to advance the vaccine into Phase III trials ends its ambition to bring the first HSV vaccine to market.

With the approval of Moderna's updated COVID-19 vaccine, doctors are hoping the shots will be available soon and Albertans ...

A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Under the EU Clinical Trials Regulation, financial incentives are not allowed for participants under 16 to prevent undue ...

While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...